Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Diana Bello Roufai, Anthony Gonçalvès, Thibault De La Motte Rouge, S. Akla, Cyriac Blonz, Julien Grenier, Joseph Gligorov, Mahasti Saghatchian, Caroline Bailleux, H. Simon, Isabelle Desmoulins, Zoé Tharin, Emmanuelle Renaud, Marion Bertho, M-A. Benderra, Suzette Delaloge, L. Robert, Paul Cottu, Jean‐Yves Pierga, Delphine Loirat, Alexandre Bertucci, Benjamin Renouf, François‐Clément Bidard, F. Lerebours